JAMA:美国预防工作组不建议用心电图筛查房颤:10秒“快照”没有比摸脉能发现更多房颤

2018-08-10 xujing 中国循环杂志

JAMA杂志近日刊登了美国预防工作组(USPSTF)声明。声明指出,采用心电图在无症状人群中进行房颤筛查的获益及风险不明确,证据不足。

JAMA杂志近日刊登了美国预防工作组(USPSTF)声明。声明指出,采用心电图在无症状人群中进行房颤筛查的获益及风险不明确,证据不足。

专责组审查了纳入135300人的17项研究。

研究表明,用心电图进行系统筛查比不筛查确实发现了新的房颤(1年内从0.6%增加至2.8%)。然而,心电图筛查并没有比摸脉发现更多的房颤。

而且研究并没有明确针对无症状房颤的筛查和治疗是否比采用常规手段诊断房颤以及治疗有症状的房颤的临床效果更好。

研究显示,华法林治疗降低与缺血性卒中风险和全因死亡率,增加出血风险,但是在研究中的患者并不是经过心电图筛查的,并且大多数房颤为持续性房颤。

有荟萃分析报告,新型口服抗凝剂降低卒中和全身栓塞局风险(比值比为0.32~0.44),增加出血风险(比值比为1.4~2.2),但置信区间宽且差异较大。组间差异无统计学意义。

Goldberger教授在述评中指出,心电图筛查的问题是10秒的快照对筛查房颤并不是很有帮助,这就像大海捞针。我们需要廉价且可以持续监测的手段,智能手表或能担此重任。

原始出处:US Preventive Services Task Force. Screening for Atrial Fibrillation With Electrocardiography: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;320(5):478-484. 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2081061, encodeId=2345208106169, content=<a href='/topic/show?id=846b20389cd' target=_blank style='color:#2F92EE;'>#不建议#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20389, encryptionId=846b20389cd, topicName=不建议)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d3459, createdName=周虎, createdTime=Mon Sep 17 01:15:00 CST 2018, time=2018-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=339321, encodeId=b1fa33932189, content=哈哈,不错耶,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Sat Aug 18 10:58:10 CST 2018, time=2018-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1551894, encodeId=2380155189456, content=<a href='/topic/show?id=6bbf618e10a' target=_blank style='color:#2F92EE;'>#查房#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61871, encryptionId=6bbf618e10a, topicName=查房)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a59514235100, createdName=smartjoy, createdTime=Sun Aug 12 03:15:00 CST 2018, time=2018-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337877, encodeId=760633e8774a, content=哈哈暴击, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Sat Aug 11 09:32:24 CST 2018, time=2018-08-11, status=1, ipAttribution=)]
    2018-09-17 周虎
  2. [GetPortalCommentsPageByObjectIdResponse(id=2081061, encodeId=2345208106169, content=<a href='/topic/show?id=846b20389cd' target=_blank style='color:#2F92EE;'>#不建议#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20389, encryptionId=846b20389cd, topicName=不建议)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d3459, createdName=周虎, createdTime=Mon Sep 17 01:15:00 CST 2018, time=2018-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=339321, encodeId=b1fa33932189, content=哈哈,不错耶,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Sat Aug 18 10:58:10 CST 2018, time=2018-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1551894, encodeId=2380155189456, content=<a href='/topic/show?id=6bbf618e10a' target=_blank style='color:#2F92EE;'>#查房#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61871, encryptionId=6bbf618e10a, topicName=查房)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a59514235100, createdName=smartjoy, createdTime=Sun Aug 12 03:15:00 CST 2018, time=2018-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337877, encodeId=760633e8774a, content=哈哈暴击, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Sat Aug 11 09:32:24 CST 2018, time=2018-08-11, status=1, ipAttribution=)]
    2018-08-18 owlhealth

    哈哈,不错耶,学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2081061, encodeId=2345208106169, content=<a href='/topic/show?id=846b20389cd' target=_blank style='color:#2F92EE;'>#不建议#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20389, encryptionId=846b20389cd, topicName=不建议)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d3459, createdName=周虎, createdTime=Mon Sep 17 01:15:00 CST 2018, time=2018-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=339321, encodeId=b1fa33932189, content=哈哈,不错耶,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Sat Aug 18 10:58:10 CST 2018, time=2018-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1551894, encodeId=2380155189456, content=<a href='/topic/show?id=6bbf618e10a' target=_blank style='color:#2F92EE;'>#查房#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61871, encryptionId=6bbf618e10a, topicName=查房)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a59514235100, createdName=smartjoy, createdTime=Sun Aug 12 03:15:00 CST 2018, time=2018-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337877, encodeId=760633e8774a, content=哈哈暴击, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Sat Aug 11 09:32:24 CST 2018, time=2018-08-11, status=1, ipAttribution=)]
    2018-08-12 smartjoy
  4. [GetPortalCommentsPageByObjectIdResponse(id=2081061, encodeId=2345208106169, content=<a href='/topic/show?id=846b20389cd' target=_blank style='color:#2F92EE;'>#不建议#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20389, encryptionId=846b20389cd, topicName=不建议)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d3459, createdName=周虎, createdTime=Mon Sep 17 01:15:00 CST 2018, time=2018-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=339321, encodeId=b1fa33932189, content=哈哈,不错耶,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Sat Aug 18 10:58:10 CST 2018, time=2018-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1551894, encodeId=2380155189456, content=<a href='/topic/show?id=6bbf618e10a' target=_blank style='color:#2F92EE;'>#查房#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61871, encryptionId=6bbf618e10a, topicName=查房)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a59514235100, createdName=smartjoy, createdTime=Sun Aug 12 03:15:00 CST 2018, time=2018-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337877, encodeId=760633e8774a, content=哈哈暴击, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Sat Aug 11 09:32:24 CST 2018, time=2018-08-11, status=1, ipAttribution=)]
    2018-08-11 smartxiuxiu

    哈哈暴击

    0

相关资讯

快速掌握肥厚型心肌病的诊治方案,一文读懂!

肥厚型心肌病是临床上较为常见的一种心肌病,因其猝死率高,现逐渐得到各国心血管医师的重视,去年我国公布了最新版《中国成人肥厚型心肌病诊断与治疗指南》(以下简称《指南》),单纯文字描述阻碍了我们迅速掌握指南的精髓,现我通过一例病例与大家共同学习以下这部指南。

挑战心电图:药物性心律失常

一名72岁的女性,每天两次口服美托洛尔5mg,每天两次氟卡胺150mg用于心脏节律控制,每天2mg醋氨甲酚用于呕吐,晕厥,疲劳持续3天。体格检查显示心率为110次/分,血压为106/78mmHg,室内空气下全身氧饱和度为98%。血清钾为3.76 mEq/L,血清镁为1.8 mg/L,血清钠为124 mEq/L,血清肌酐为1.1 mg/dL。ECG的显示如图1所示。诊断是什么,应该如何治疗?

2018 USPSTF建议声明:心电图筛查心血管疾病风险

2018年6月,美国预防医学工作组(USPSTF)发布了心电监测筛查心血管疾病风险的建议声明,本文是对2012年USPSTF冠心病心电图筛查建议的更新,USPSTF不建议心血管疾病风险低的无症状成人筛查休息和运动时心电图用于预防心血管疾病。

一份“蹊跷”的心电图,如何揪出“元凶”?

今天就来讲一讲一种销声匿迹多年的武林绝学:一石二鸟。可凭四两拨千斤之势,决胜千里之外。哈哈,不扯了,让我们来看看Vereckei教授提供的精彩病例[1]。

JACC:术后即刻12导联心电图可作为TAVR后晚期传导缺陷的预测因子

对于以下无右束支传导阻滞的患者TAVR后立即移除临时起搏器是安全的:1)窦性心律、伴PR间期<240ms且QRS间期<150ms;或2)房颤并且QRS间期<140ms。